Recently, it was reported that VDL has the inhibitory effect on protein tyrosine phosphatase 1B (PTP-1B), so it can be used as an "insulin sensitizer" in the treatment of type 2 diabetes mellitus (T2DM) [10–12]. Here, PTPN1 is linked to diabetes mellitus.